(20) observed that activated AKT in sunitinib-resistant RCC cells downregulates FOXO1 and FOXO3a, which subsequently activates the transcription of lncARSR, resulting in its high expression in drug-resistant cells. This evidence concerns the gene FOXO3 and renal cell carcinoma.